HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Kalberg Selected Research

Dyspnea (Shortness of Breath)

10/2013Efficacy and safety of once-daily umeclidinium/vilanterol 62.5/25 mcg in COPD.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Kalberg Research Topics

Disease

7Asthma (Bronchial Asthma)
09/2001 - 06/2000
2Chronic Obstructive Pulmonary Disease (COPD)
10/2013 - 01/2005
1Dyspnea (Shortness of Breath)
10/2013
1Inflammation (Inflammations)
09/2001

Drug/Important Bio-Agent (IBA)

6Fluticasone (Cutivate)FDA LinkGeneric
09/2001 - 06/2000
5Albuterol (Salbutamol)FDA LinkGeneric
10/2013 - 03/2001
4Salmeterol Xinafoate (Serevent)FDA Link
01/2005 - 05/2001
4zafirlukast (Accolate)FDA LinkGeneric
08/2001 - 06/2000
4Adrenal Cortex Hormones (Corticosteroids)IBA
07/2001 - 06/2000
3LeukotrienesIBA
07/2001 - 06/2000
2montelukast (Singulair)FDA Link
09/2001 - 03/2001
1GSK573719IBA
10/2013
1vilanterolIBA
10/2013
1Muscarinic AntagonistsIBA
10/2013
1Bronchodilator Agents (Bronchodilators)IBA
01/2005
1Dihydrotachysterol (AT 10)IBA
09/2001
1Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA
01/2001

Therapy/Procedure

4Therapeutics
09/2001 - 06/2000